Skip to content

THC vs. CBD: What You Need to Know

THC vs. CBD: What You Need to Know

With the rising demand of natural medicines, medical marijuana compounds THC and CBD are starting to make a name for themselves more than ever before. These two compounds have a wide range of health benefits, making it understandable why patients and physicians would be interested in this alternative treatment option. Although these two compounds are derived from the same source and appear to be virtually identical, they affect the human body quite differently.

Cannabinoids and the Endocannabinoid System

Before we dissect these two compounds, it’s important to understand where they come from and what part of the body they affect. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) are just two of the 85 known cannabinoids found in the Cannabis plant.

“A cannabinoid is a compound that interacts directly with our body’s Endocannabinoid System (ECS), which in short, is a network of receptors that interact with cannabinoids to maintain vital functions throughout our body.” (Medium.com/CBD-Origin).

In 1988, scientists discovered the first cannabinoid receptor, with the second coming to light in 1993. In 1995, these two receptors were identified as CB1 and CB2 receptors. “The interaction between the CB1 and CB2 receptors with cannabinoids like CBD and THC is the catalyst for health benefits such as pain relief, anxiety relief, appetite stimulation, mood management and more.”

Molecular Makeup

As far as chemical makeup goes, THC and CBD are the exact same: 21 carbon atoms, 30 hydrogen atoms and two oxygen atoms. Take a look at the figure below. The differentiator between the two compounds is the placement of one single atom through their structure. For reference, one atom is one million times smaller than a human hair, so we’re talking about a microscopic difference.

While a microscopic difference might not seem like a big deal, it’s exactly what makes these two compounds react with our body in surprisingly different ways. These different reactions are due to the fact that THC and CBD have different molecular structures, causing them to have dissimilar interactions with CB1 and CB2.

THC vs. CBD: How Each Affects the Body

Despite their near identical structures, THC and CBD differ when it comes to psychoactive effects. In fact, CBD is a non-psychoactive compound, meaning it doesn’t produce the “high” feeling associated with THC.

Due to its molecular structure, THC is able to bind strongly with CB1 receptors. When this bond is formed, the reaction creates signals that are then sent to the brain. These reactions are the core source of the well-known psychoactive response of “getting high”.

On the complete opposite side of the spectrum, CBD does not bond strongly with CB1 receptors and can even negate the bond between THC and the CB1 receptors. By doing this, those psychoactive effects induced by THC are completely neutralized.

“While THC certainly offers tremendous health benefits, its mind-altering effects aren’t preferred by everyone. CBD, on the other hand, can deliver many of the same benefits of THC without inducing its psychoactive effects. Plus, when using CBD vs THC, you typically won’t be breaking the law.” (Medium.com/CBD-Origin)

Are YOU ready to put CBD and THC to the test with your patients? Join Arfinn Med for FREE to get real medical marijuana treatment efficacies, discuss treatment options with other licensed physicians and stay up-to-date on all of the latest industry findings.

Looking for more information about CBD and THC? Check out these two articles to learn more about the health benefits and side effects:

https://medium.com/cbd-origin/cbd-vs-thc-the-difference-explained-b3cfc1da52f0

https://www.healthline.com/health/cbd-vs-thc#psychoactive-components

Stories you may be interested in

Cannabis reduces blood pressure in older adults, according to Ben-Gurion University researchers

Beer-Sheva, Israel…February 8, 2021 – A new discovery by researchers from Ben-Gurion University of the Negev (BGU) and its affiliated Soroka University Medical Center shows that medical cannabis may reduce blood pressure in older adults. The study, published in the European Journal of Internal Medicine, is the first of its kind to focus on the effect…
Read More

Cannabis and Seniors

As more and more research comes out regarding the medical benefits of cannabis, it’s important to keep up with new research as it becomes available.  Here at Arfinn Med, we constantly review new studies and look at our own deidentified efficacy data to try to find any additional insights we can relay to our registered…
Read More

Texas House Bill 3703: What You Need to Know

The state of Texas has been in the news in recent months as the legislature review House Bill 3703. This bill relates to “the prescription of low-THC cannabis for medical use by certain qualified physicians to patients with [specific] qualifying conditions”. Originally filed in March of 2019, this bill made its way through the house…
Read More

Cannabis for Treating IBD: Hope or Hype?

Nausea, abdominal pain and changes in appetite. These are all things that can significantly impact one’s wellbeing if left untreated, yet they have all shown marked improvements when associated with cannabis. Yet, less is known about the effects of cannabis on inflammatory bowel disease, or IBD, a chronic inflammatory condition that impacts the gastrointestinal tract…
Read More

New study finds cannabis effective for treating migraines

A study published last month in the Journal of Pain found a statistically significant reduction in migraine and headache symptoms and recurrences among patients who used cannabis for treatment.Smoking cannabis reduced the severity and length of migraine episodes by nearly half. Researchers concluded that headache and migraine severity were reduced by nearly 50% after using cannabis. The study, conducted by researchers…
Read More

Former Detroit Lions players announce partnership with Harvard to study marijuana

Former Detroit Lions football players Calvin Johnson and Robert Sims are expanding their emerging cannabis enterprise into the field of medicine. The pair announced an agreement Thursday with the International Phytomedicines and Medical Cannabis Institute at Harvard University, which is researching the benefits of medical marijuana and looking at the best ways to deliver cannabis-based…
Read More

Leave a Comment

You must be logged in to post a comment.